Cary J. Claiborne - Chief Executive Officer, Director at Adial Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ADIL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cary J. Claiborne since 9/12/2023

Holdings reported by Cary J. Claiborne for Adial Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.52M $639K $0.42 May 23, 2023 Direct
Stock Option (Right to Buy) 60K Mar 25, 2024 Direct Common Stock

Transactions reported by Cary J. Claiborne for Adial Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.